scispace - formally typeset
A

Alberto Bavelloni

Researcher at I.O.R.

Publications -  70
Citations -  1876

Alberto Bavelloni is an academic researcher from I.O.R.. The author has contributed to research in topics: Signal transduction & Phosphorylation. The author has an hindex of 24, co-authored 64 publications receiving 1631 citations. Previous affiliations of Alberto Bavelloni include University of Ferrara & University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

MiRNA-210: A Current Overview.

TL;DR: A current overview on the involvement of miRNA-210 in biological processes and diseases is provided and a variety of miR-210 targets have been identified pointing to its role, not only in mitochondrial metabolism, but also in angiogenesis, the DNA damage response, cell proliferation, and apoptosis.
Journal ArticleDOI

Tear proteomics in evaporative dry eye disease.

TL;DR: Analysis of tear protein variations in patients suffering from dry eye symptoms in the presence of tear film instability but without epithelial defects shows that tear protein changes anticipate the onset of more extensive clinical signs in early stage dry eye disease.
Journal ArticleDOI

Interleukin 1 alpha stimulates nuclear phospholipase C in human osteosarcoma SaOS-2 cells.

TL;DR: It is shown that in human osteosarcoma SaOS-2 cells the treatment with IL-1 alpha is able to evoke a rapid and transient increase of nuclear phospholipase C (PLC) activity and a parallel decrease ofnuclear phosphatidylinositol monophosphate and phosph atidyl inositol bisphosphate.
Journal ArticleDOI

Prohibitin 2: At a communications crossroads

TL;DR: This review focuses on PHB2 and new data concerning its cellular functions both in complex with PHB1 and independent ofPHB1, placing these proteins among the key regulators of pathologies such as cancer, neuromuscular degeneration, and other metabolic diseases.
Journal ArticleDOI

Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I

TL;DR: Investigation of the role of PI 3‐kinase in IL‐1 signalling indicates that it is likely to be an important mediator of someIL‐1 effects, providing docking sites for additional signalling molecules.